| Literature DB >> 35658851 |
Siyue Han1, Guangju Mo1, Tianjing Gao1, Qing Sun1, Huaqing Liu2, Min Zhang3.
Abstract
BACKGROUND: Multimorbidity among older adults, which is associated with added functional decline and higher health care utilization and mortality, has become increasingly common with the dramatic acceleration of ageing in China. The purpose of this study was to reveal age, sex, residence, and region- specific prevalence and patterns of multimorbidity among older adults in China.Entities:
Keywords: Ageing; Association rule mining; China; Chronic disease; Multimorbidity
Mesh:
Year: 2022 PMID: 35658851 PMCID: PMC9166487 DOI: 10.1186/s12889-022-13506-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 4.135
Fig. 1The prevalence of the number of multimorbidities (A), and the multimorbidity of the 14 chronic diseases or conditions in the CLHLS (B)
Fig. 2Geographical distribution of the prevalence of multimorbidity in the CLHLS. (A) MM2+ (B) MM3+
Age-, sex-, residence-, and region -specific prevalence of 14 chronic diseases or conditions of participants
| Chronic disease or condition | Total | Age | Sex | Residence | Region | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65–79 years | 80–89 years | ≥ 90 years | Male | Female | Urban | Rural | East | West | South | North | Central | ||||||
| Hypertension | 6538(42.8) | 2468(47.3) | 1935(48.8) | 2135(35.0) | < 0.001 | 2762(41.0) | 3776(44.2) | < 0.001 | 3905(46.0) | 2633(38.8) | < 0.001 | 2943(47.3) | 773(38.8) | 1191(40.0) | 763(47.7) | 868(35.2) | < 0.001 |
| Affective disorders | 4302(28.2) | 1370(26.3) | 1219(30.7) | 1713(28.1) | < 0.001 | 1718(25.5) | 2584(30.3) | < 0.001 | 2369(27.9) | 1933(28.5) | 0.428 | 1796(28.9) | 550(27.6) | 918(30.7) | 339(21.2) | 699(28.4) | < 0.001 |
| Cardiovascular diseases | 3781(24.8) | 1358(26.0) | 1153(29.1) | 1270(20.8) | < 0.001 | 1649(24.5) | 2132(25.0) | 0.465 | 2437(28.7) | 1344(19.8) | < 0.001 | 1721(27.7) | 404(20.3) | 468(15.6) | 597(37.3) | 591(24.0) | < 0.001 |
| Vision impairment | 2183(14.3) | 590(11.3) | 626(15.8) | 967(15.9) | < 0.001 | 821(12.2) | 1362(16.0) | < 0.001 | 1479(17.4) | 704(10.4) | < 0.001 | 885(14.2) | 257(12.9) | 365(12.2) | 391(24.5) | 285(11.6) | < 0.001 |
| Rheumatoid arthritis | 2065(13.5) | 796(15.3) | 616(15.5) | 653(10.7) | < 0.001 | 731(10.8) | 1334(15.6) | < 0.001 | 1236(14.6) | 829(12.2) | < 0.001 | 745(12.0) | 322(16.2) | 464(15.5) | 257(16.1) | 277(11.2) | < 0.001 |
| Respiratory diseases | 1550(10.1) | 455(8.7) | 480(12.1) | 615(10.0) | < 0.001 | 857(12.7) | 693(8.1) | < 0.001 | 960(11.3) | 590(8.7) | < 0.001 | 649(10.4) | 283(14.2) | 218(7.3) | 164(10.3) | 236(9.6) | < 0.001 |
| Diabetes | 1447(9.5) | 695(13.3) | 439(11.1) | 313(5.1) | < 0.001 | 609(9.0) | 838(9.8) | 0.101 | 1037(12.2) | 410(6.0) | < 0.001 | 654(10.5) | 180(9.0) | 192(6.4) | 268(16.8) | 153(6.2) | < 0.001 |
| Dyslipidemia | 742(4.9) | 390(7.5) | 210(5.3) | 142(2.3) | < 0.001 | 311(4.6) | 431(5.0) | 0.214 | 557(6.6) | 185(2.7) | < 0.001 | 369(5.9) | 85(4.3) | 59(2.0) | 160(10.0) | 69(2.8) | < 0.001 |
| Gastrointestinal ulcer | 654(4.3) | 261(5.0) | 196(4.9) | 197(3.2) | < 0.001 | 281(4.2) | 373(4.3) | 0.542 | 391(4.6) | 263(3.9) | 0.030 | 330(5.3) | 66(3.3) | 97(3.2) | 59(3.7) | 102(4.1) | < 0.001 |
| Biliary diseases | 593(3.9) | 244(4.7) | 168(4.2) | 181(3.0) | < 0.001 | 214(3.2) | 379(4.4) | < 0.001 | 396(4.7) | 197(2.9) | < 0.001 | 277(4.5) | 111(5.6) | 42(1.4) | 75(4.7) | 88(3.6) | < 0.001 |
| Neurological diseases | 471(3.1) | 60(1.1) | 106(2.7) | 305(5.0) | < 0.001 | 166(2.5) | 305(3.6) | < 0.001 | 278(3.3) | 193(2.8) | 0.140 | 195(3.1) | 75(3.8) | 63(2.1) | 61(3.8) | 77(3.1) | 0.004 |
| Cancer | 201(1.3) | 84(1.6) | 59(1.5) | 58(1.0) | 0.005 | 105(1.6) | 96(1.1) | 0.020 | 140(1.6) | 61(0.9) | < 0.001 | 108(1.7) | 19(1.0) | 15(0.5) | 41(2.6) | 18(0.7) | < 0.001 |
| Chronic nephritis | 147(1.0) | 60(1.1) | 49(1.2) | 38(0.6) | 0.002 | 76(1.1) | 71(1.4) | 0.063 | 101(1.2) | 46(0.8) | 0.002 | 49(0.8) | 18(0.9) | 31(1.0) | 34(2.1) | 15(0.6) | < 0.001 |
| Hepatitis | 61(0.4) | 38(0.7) | 11(0.2) | 12(0.1) | < 0.001 | 34(0.5) | 27(0.8) | 0.067 | 38(0.4) | 23(0.3) | 0.354 | 27(0.4) | 9(0.5) | 11(0.4) | 7(0.4) | 7(0.3) | 0.864 |
| ≥ 1 disease or condition | 11,500(75.3) | 4025(77.2) | 3196(80.6) | 4279(70.2) | < 0.001 | 4990(74.0) | 6510(76.3) | 0.002 | 6608(77.8) | 4892(72.1) | < 0.001 | 4797(77.1) | 1489(74.7) | 2134(71.3) | 1287(80.5) | 1793(72.7) | < 0.001 |
| Multimorbidty (2+) | 6737(44.1) | 2398(46.0) | 1998(50.4) | 2341(38.4) | < 0.001 | 2805(41.6) | 3932(46.1) | < 0.001 | 4116(48.5) | 2661(39.2) | < 0.001 | 2915(46.8) | 859(43.1) | 1138(38.0) | 865(54.1) | 960(38.9) | < 0.001 |
| Multimorbidty (3+) | 3506(23.0) | 1322(25.4) | 1087(27.4) | 1097(18.0) | < 0.001 | 1407(20.9) | 2099(24.6) | < 0.001 | 2303(27.1) | 1203(17.7) | < 0.001 | 1565(25.1) | 444(22.3) | 535(17.9) | 521(32.6) | 441(17.9) | < 0.001 |
Significant at P- value< 0.05 by Chi-square/ Fisher Exact test
Top ten in combination clusters with multimorbidity
| Rank | Dyads of morbidity | Triads of morbidity | ||
|---|---|---|---|---|
| Combination | Combination | |||
| 1 | HTN + CVD | 2516(16.5) | HTN + CVD + AD | 975(6.4) |
| 2 | HTN + AD | 2149(14.1) | HTN + CVD + VI | 682(4.5) |
| 3 | CVD + AD | 1473(9.6) | HTN + CVD + DM | 663(4.3) |
| 4 | HTN + VI | 1341(8.8) | HTN + CVD + RA | 646(4.2) |
| 5 | HTN + RA | 1254(8.2) | HTN + AD + RA | 526(3.4) |
| 6 | HTN + DM | 1233(8.0) | HTN + AD + VI | 482(3.2) |
| 7 | CVD + VI | 962(6.3) | HTN + VI + RA | 471(3.1) |
| 8 | AD + RA | 924(6.0) | HTN + AD + DM | 470(3.1) |
| 9 | CVD + RA | 896(5.9) | HTN + CVD + RD | 464(3.0) |
| 10 | HTN + RD | 824(5.4) | HTN + CVD + DL | 409(2.7) |
Abbreviations: HTN hypertension, CVD cardiovascular diseases, AD affective disorders, VI vision impairment, RA rheumatoid arthritis, DM diabetes, RD respiratory diseases, DL dyslipidemia
The 10 rules with the strongest associations in the total population
| Rules | Support | Confidence | Lift |
|---|---|---|---|
| {Hypertension, Rheumatoid arthritis} = > {Vision impairment} | 3.1% | 37.6% | 2.39 |
| {Hypertension, Vision impairment} = > {Rheumatoid arthritis} | 3.1% | 35.1% | 2.35 |
| {Dyslipidemia} = > {Cardiovascular diseases} | 3.3% | 59.9% | 2.32 |
| {Hypertension, Respiratory diseases} = > {Cardiovascular diseases} | 3.0% | 56.3% | 2.18 |
| {Diabetes, Hypertension} = > {Cardiovascular diseases} | 4.3% | 54.2% | 2.10 |
| {Rheumatoid arthritis} = > {Vision impairment} | 4.8% | 32.4% | 2.06 |
| {Vision impairment} = > {Rheumatoid arthritis} | 4.8% | 30.8% | 2.06 |
| {Hypertension, Rheumatoid arthritis} = > {Cardiovascular diseases} | 4.2% | 51.5% | 2.00 |
| {Cardiovascular diseases, Diabetes} = > {Hypertension} | 4.3% | 85.9% | 1.98 |
| {Hypertension, Vision impairment} = > {Cardiovascular diseases} | 4.5% | 50.9% | 1.97 |